Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3

Growth Factors

Volumn 16, Issue 1, 1998, Pages 53-67

  Walker, Francesca ^a   Hibbs, Margaret L ^a   Zhang, Hui Hua ^a   Jorge Gonez, L ^a   Burgess, Antony W ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

Affinity; Epidermal growth factor receptor; Phosphorylation; Structure; Tyrosine kinase

Indexed keywords

ADENOSINE TRIPHOSPHATE; EPIDERMAL GROWTH FACTOR RECEPTOR; MUTANT PROTEIN; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INTERNALIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY;

EID: 0031795791     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977199809017491     Document Type: Article

References (43)

1. Bellot, F., Molenaar, W., Kris, K., Mirakhur, B., Verlaan, I., Ullrich, A., Schlessinger, J. and Felder, S. (1990) High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. J. Cell Biol. 110, 491-502.
2. Burgess, A.W., Lloyd, C.J. and Nice, E.C. (1983) Murine epidermal growth factor: heterogeneity on high resolution ion-exchange chromatography. EMBO J. 2, 2065-2069.
3. Carraway, K.L. III and Cantley, L.C. (1994) A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78, 5-8.
4. Chang, C.P., Kao, J.P., Lazar, C.S., Walsh, B.J., Wells, A., Wiley, H.S., Gill, G.N. and Rosenfeld, M.G. (1991) Ligandinduced internalization and increased cell calcium are mediated via distinct structural elements in the carboxyl terminus of the epidermal growth factor receptor. J. Biol. Chem. 266, 23467-23470.
5. Chen, W.S., Lazar, C.S., Poenie, M., Tsien, R.Y., Gill, G.N. and Rosenfeld, M.G. (1987) Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature 328, 820-823.
6. Coker, K.J., Staros, J.V. and Guyer, C.A. (1994) A kinasenegative epidermal growth factor receptor that retains the capacity to stimulate DNA synthesis. Proc. Nail. Acad. Sci. USA 91(15), 6967-6971.
7. Derynck, R., Roberts, A.B., Winkler, M.E., Chen, E.Y. and Goeddel, D.V. (1984) Human transforming growth factoralpha: precursor structure and expression in E. coli. Cell 38, 287-297.
8. Felder, S., La Vin, J., Ullrich, A. and Schlessinger, J. (1992) Kinetics of binding, endocytosis, and recycling of EGF receptor mutant. J. Cell. Biol. 117, 203-212.
9. Fowler, K.J., Walker, F., Alexander, W., Hibbs, M.L., Nice, E.C., Bohmer, R.M., Mann, G.B., Thumwood, C, Maglitto, R., Danks, J.A., Chetty, R., Burgess, A.W. and Dunn, A.R. (1995) A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA 92, 1465-1469.
10. Fracker, P.J. and Speck, J.C. (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem. Biophys. Commun. 80, 849-857.
11. Gill, G.N., Kawamoto, T., Cochet, C., Le, A., Sato, J.D., Masui, H., McLeod, A., and Mendelsohn, J. (1984) Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem. 259, 7755-7760.
12. Glenney, J.R.Jr., Chen, W.S., Lazar, C.S., Walton, G.M., Zokas, L.M., Rosenfeld, M.G. and Gill, G.N. (1988) Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell 52, 675-684.
13. Gotoh, N., Tojo, A., Muroya, K., Hashimoto, Y., Hattori, S., Nakamura, S., Takenawa, T., Yazaki, Y. and Shibuya, M. (1994) Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of She protein and Shc-Grb2/ASH association and retains mitogenic activity. Proc. Natl. Acad. Sci. USA 91, 167-171.
14. Gray, G.M., and Macara, I.G. (1988) The pp60v-src tyrosine kinase desensitizes epidermal growth factor binding to 3T3 fibroblasts by two distinct protein kinase C-independent mechanisms. J. Biol. Chem. 263, 10714-10719.
15. Groenen, L.C., Walker, F., Burgess, A.W. and Treutlein, H.R. (1997) A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer? Biochemistry 36 3826-3836.
16. Hack, N., Sue-A-Quan, A., Mills, G.B. and Skorecki, K.L. (1993) Expression of human tyrosine kinase-negative epidermal growth factor receptor amplifies signaling through endogenous murine epidermal growth factor receptor. J. Biol. Chem. 268, 26441-26446.
17. Haigler, H.T., Maxfield, F.R., Willingham, M.C. and Pastan, I. (1980) Dansylcadaverine inhibits internalization of 1251-epidermal growth factor in BALE 3T3 cells. J. Biol. Chem., 257, 1239-1241.
18. Hatakeyama, M., Mori, H., Doi, T. and Taniguchi, T. (1989) A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59, 837-845.
19. Holmes, W.E., Sliwkowski, M.X., Akita, R.W., Fjenzel, W.J., Lee, J., Park, J.W., Yansura, D., Abadi, N., Raab, H., Lewis, G.D. et al. (1992) Identification of heregulin, a specific activator of p185erbB2. Science 256, 1205-1210.
20. Honegger, A.M., Dull, T.J., Felder, S., Van Obberghen, E., Bellot, F., Szapary, D., Schmidt, A., Ullrich, A. and Schlessinger, J. (1987a) Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell 51, 199-209.
21. Honegger, A.M., Szapary, D., Scmidt, A., Lyall, R., Van Obberghen, E., Dull, T.J., Ullrich, A. and Schlessinger, J. (1987b) A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate protooncogene expression and DNA synthesis. Mol. Cell. Biol. 7, 4568-4571.
22. Kamps, M.P. and Sefton, B.M. (1986) Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src. Mol. Cell. Biol. 6, 751-757.
23. Kornilova, E., Sorkina, T., Beguinot, L. and Sorkin, A. (1996) Lysosomal targeting of epidermal growth factor receptors via a kinase-dependent pathway is mediated by the receptor carboxyl-terminal residues 1022-1123. J. Biol. Chem. 271(48), 30340-30346.
24. Kraus, M.H., Issing, W., Miki, T., Popescu, N.C. and Aaronson, S.A. (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci., USA 86, 9193-9197.
25. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
26. Lamaze, C. and Schmid, S.L. (1995) Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase. J. Cell. Biol. 129, 47-54.
27. Lemmon, M.A. and Schlessinger, J. (1994) Regulation of signal transduction and signal diversity by receptor oligomerization. TIBS 19, 459-463.
28. Luetteke, N.C., Phillips, H.K., Qiu, T.H., Copeland, N.G., Earp, H.S., Jenkins, N.A. and Lee, D.C. (1994) The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes and Development 8, 399-413.
29. Morris, C.F., Young, I.G. and Hapel, A.J. (1990) Molecular and cellular biology of interleukin-3. Immunol. Ser. 49, 177-214.
30. Munson, P.J. (1981) A User's Guide to Ligand. NIH Bethesda, MD.
31. Palacios, R. and Steinmetz, M. (1985) Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41, 727-734.
32. Robinson, M.J., Harkins, P.C., Zhang, J., Baer, R., Haycock, J.W., Cobb, M.H. and Goldsmith, F.J. (1996) Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5′-triphosphate. Biochemistry 35, 5641-5646.
33. Savage, C.R., Inagami, T. and Cohen, S. (1972) The primary structure of epidermal growth factor. J. Biol. Chem. 247, 7612-7621.
34. Selva, E., Raden, D.L. and Davis, R.J. (1993) Mitogen-activated protein kinase stimulation by a tyrosine kinase-negative epidermal growth factor receptor. J. Biol. Chem. 268, 2250-2254.
35. Soler, C., Alvarez, C.V., Beguinot, L. and Carpenter, G. (1994) Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Oncogene 9, 2207-2215.
36. Sorkin, A., Krolenko, S., Kudrjavtceva, N., Lazebnik, J., Teslenko, L., Soderquist, A.M. and Nikolsky, N.J. (1991) Recycling of epidermal growth factor-receptor complexes in A431 cells: identification of dual pathways. J. Cell. Biol. 112, 55-63.
37. Sorkin, A., Mazzotti, M., Sorkina, T., Scotto, L. and Beguinot, L. (1996) Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif. J. Biol. Chem. 271(23), 13377-13384.
38. Stern, D.F., Heffernan, P.A. and Weinberg, R.A. (1986) p185, a product of the neu proto-oncogene, is a receptor like protein associated with tyrosine kinase activity. Mol. Cell. Biol. 6, 1729-1740.
39. Ullrich, A. and Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
40. Walker, F. and Burgess, A.W. (1988) Transmodulation of the epidermal-growth-factor receptor in permeabilized 3T3 cells. Biochem. J. 256, 109-115.
41. Walker, F., deBlaquiere, J. and Burgess, A.W. (1993) Translocation of pp60c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor. J. Biol. Chem. 268, 19552-19558.
42. Walker, F., Nice, E.G., Fabri, L., Moy, F.J., Liu, J.F., Wu, R., Scheraga, H.A. and Burgess, A.W. (1990) Resistance to receptor-mediated degradation of a murine epidermal growth factor analogue (EGF-Val-47) potentiates its mitogenic activity. Biochemistry 29, 10635-10640.
43. Wright, J.D., Reuter, C.W. and Weber, M.J. (1995) An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors. J. Biol. Chem. 270, 2085-12093.